YCBD - cbdMD Quarterly EPS earnings growth
The quarterly EPS growth for cbdMD, Inc. (YCBD) demonstrates moderate cyclicality in CBD product sales, characterized by a pre-holiday surge in demand. The company's revenues rely on customer loyalty amid fierce competition and advertising barriers. Business development is based on packaging automation and the implementation of AI-driven logistics. The value of 46.80 sets the current metric, concluding the current period of earnings per share dynamics.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_YCBD_-_cbdMD-Inc._-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "cbdMD (YCBD): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/13/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for cbdMD, Inc. (YCBD)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
- earnings and market multiples details:
YCBD - Final Profit|Projected Future Earnings cbdMD, Inc.|YCBD - Business Payback Period|Future Price to Earnings cbdmd.com|YCBD - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple cbdMD Corp|YCBD - Operating profit before deduction of amortization|Net earnings per share for the last 12 months cbdMD|YCBD - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months cbdmd.com|YCBD - Earnings per share growth rate in current year|Earnings growth forecast for next year cbdMD, Inc.
- sales revenue and business income indicators:
Summary company analysis:cbdMD, Inc.
To select high-quality assets, an investor must confirm profit sustainability by comparing current net income per share with results from previous quarters. This metric measures the growth rate of returns, which, combined with the transparent corporate governance of cbdMD, Inc. (YCBD), allows for an assessment of market share retention efficiency through the quarterly EPS growth history.
Main competitors
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PRGO (Perrigo)|ALVO - Year-over-year net earnings per share growth for the last 12 months|Liquidia Technologies - Quarterly EPS earnings growth|GLPG: Year-over-year earnings per share growth for the last twelve months|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|Year-over-year earnings per share growth for the last twelve months Amphastar Pharmaceuticals, Inc.|Year-over-year net earnings per share growth for the last 12 months Pacira Pharmaceuticals (PCRX)|Quarterly EPS earnings growth SPRY|Theravance Corp - Year-over-year earnings per share growth for the last 12 months|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Tonix Pharma TNXP|sxtchina.com (SXTC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EPRX|BHST (BioHarvest Sciences) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months invizyne.com (EXOZ)|Year-over-year net earnings per share growth for the last 12 months ORMP (Oramed Pharmaceuticals)|Year-over-year net earnings per share change for the last twelve months enterabio.com|MindWalk - Year-over-year net earnings per share growth for the last 12 months|ABVC BioPharma, Inc (ABVC) - Earnings per share growth in annualized terms for the last twelve months|Cumberland Pharmaceuticals - Quarterly EPS earnings growth|quantumbiopharma.com (QNTM) - Year-over-year net earnings per share growth for the last 12 months|FGEN: Quarterly EPS earnings growth|TELO (Telomir Pharmaceuticals Inc) - Year-over-year earnings per share growth for the last twelve months|RANI (Rani Therapeutics Holdings) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SNYR (Synergy CHC Corporation)|Year-over-year earnings per share growth for the last twelve months Rallybio Corporation (RLYB)|LEXX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth PULM (Pulmatrix)|Year-over-year earnings per one share growth for the last 12 months PTHL|Aptorum - Quarterly EPS earnings growth|LYRA - Quarterly EPS earnings growth|Impact BioMedical (IBO) - Year-over-year earnings per share growth for the last twelve months|TNF Pharmaceuticals, Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months PainReform|Year-over-year net earnings per share growth for the last 12 months Auris Medical (CYTO)|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth OptiNose Corp (OPTN)|Pieris Pharmaceuticals - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PROC|PTPI - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Qilian International Holding Group|SLRN (ACELYRIN, Inc.) - Year-over-year net earnings per share growth for the last 12 months|TFFP: Year-over-year earnings per share growth rate for the last twelve months
